文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

嵌入MnO纳米颗粒的热响应性NDP水凝胶用于胰腺癌术后抗复发治疗。

Thermoresponsive NDP hydrogel embedded with MnO nanoparticles for postoperative antirecurrence therapy in pancreatic cancer.

作者信息

Yuan Zhongxu, Ma Shuai, Yan Liang, Xu Man, Liu Dongquan, Wang Weicheng, Han Bowen, Chen Gan, Wang Zhengguang

机构信息

Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, No. 218 Jixi Road, Shushan District, Hefei, 230022, Anhui, China.

Department of General Surgery, Anhui No. 2 Provincial People's Hospital, No. 1868 Dangshan and North Second Ring Road, Yaohai District, Hefei, 230041, Anhui, China.

出版信息

Sci Rep. 2025 Jul 2;15(1):23570. doi: 10.1038/s41598-025-08431-2.


DOI:10.1038/s41598-025-08431-2
PMID:40604217
Abstract

Surgical resection remains a potentially curative treatment option for pancreatic cancer (PC). However, the high rate of local tumor recurrence and poor prognosis severely limit its therapeutic efficacy. In this study, we report an injectable thermosensitive hydrogel platform (designated as NDP@MnO hydrogel) that exhibits excellent biocompatibility, photothermal performance, and wet adhesion properties, specifically designed for precise post-operative therapy. This thermosensitive system innovatively combines shear-thinning injectability, dopamine-mediated tissue adhesion, and MnO-enhanced photothermal ablation capabilities. By precisely targeting hyperthermia to the moist and irregular pancreatic resection margins during the sol-gel transition and subsequent exposure to an 808 nm laser, this approach can effectively and selectively eliminate residual tumor cells while minimizing collateral damage to adjacent healthy tissues. Notably, pre-clinical studies have demonstrated that this approach significantly reduces the locoregional recurrence rate in pancreatic cancer models, thereby offering a promising solution to the critical issue of postoperative recurrence.

摘要

手术切除仍然是胰腺癌(PC)潜在的治愈性治疗选择。然而,局部肿瘤高复发率和不良预后严重限制了其治疗效果。在本研究中,我们报告了一种可注射的热敏水凝胶平台(命名为NDP@MnO水凝胶),它具有优异的生物相容性、光热性能和湿粘附特性,专为精确的术后治疗而设计。这种热敏系统创新性地结合了剪切变稀可注射性、多巴胺介导的组织粘附性和MnO增强的光热消融能力。通过在溶胶-凝胶转变过程中以及随后暴露于808nm激光时,将热疗精确靶向到潮湿且不规则的胰腺切除边缘,这种方法可以有效且选择性地消除残留肿瘤细胞,同时将对相邻健康组织的附带损伤降至最低。值得注意的是,临床前研究表明,这种方法显著降低了胰腺癌模型中的局部区域复发率,从而为术后复发这一关键问题提供了一个有前景的解决方案。

相似文献

[1]
Thermoresponsive NDP hydrogel embedded with MnO nanoparticles for postoperative antirecurrence therapy in pancreatic cancer.

Sci Rep. 2025-7-2

[2]
Theragenerative injectable bone-adhesive hydrogels for combined photothermal osteosarcoma therapy and bone repair.

Biomater Sci. 2025-6-25

[3]
A photothermal-enhanced thermoelectric nanosheet incorporated with zwitterionic hydrogels for wound repair and bioelectronics.

Acta Biomater. 2025-6-15

[4]
Hybrid Nanocarrier Delivers Immuno-Photothermal Therapy to Modulate Pancreatic Tumor Microenvironment.

ACS Appl Bio Mater. 2025-6-16

[5]
Management of urinary stones by experts in stone disease (ESD 2025).

Arch Ital Urol Androl. 2025-6-30

[6]
2,6-Pyridinedicarboxylic Acid Covalently Bound Polydopamine for Enhanced Tumor Photothermal Therapy in NIR-I and NIR-II.

ACS Appl Mater Interfaces. 2025-6-18

[7]
Dual-laser "808 and 1,064 nm" strategy that circumvents the Achilles' heel of photothermal therapy.

Proc Natl Acad Sci U S A. 2025-6-17

[8]
Sustained-release hydrogel system for preventing postoperative tumor recurrence through synergistic immune signal enhancement for T cell activation.

J Colloid Interface Sci. 2025-6-9

[9]
Block cationic copolymer/quaternary ammonium chitosan-based composite antibacterial hydrogel dressings with NIR photothermal effects for bacteria-infected wound healing.

Int J Biol Macromol. 2025-2

[10]
A hydrogel crosslinked with mixed-valence copper nanoclusters for diabetic wound healing.

Acta Biomater. 2025-6-15

本文引用的文献

[1]
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): final report of a randomised, open-label, phase 3 trial.

Lancet Oncol. 2025-3

[2]
Recent advances of injectable in situ-forming hydrogels for preventing postoperative tumor recurrence.

Drug Deliv. 2024-12

[3]
The use of nanomaterials as drug delivery systems and anticancer agents in the treatment of triple-negative breast cancer: an updated review (year 2005 to date).

Discov Nano. 2024-9-3

[4]
Progress of Nanomaterials Based on Manganese Dioxide in the Field of Tumor Diagnosis and Therapy.

Int J Nanomedicine. 2024

[5]
Dendritic Cell-Based Immunotherapy in Patients With Resected Pancreatic Cancer.

J Clin Oncol. 2024-9-10

[6]
Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial.

Lancet Gastroenterol Hepatol. 2024-3

[7]
Hypoxia induces immunosuppression, metastasis and drug resistance in pancreatic cancers.

Cancer Lett. 2023-9-1

[8]
Gold nanoparticles and gold nanorods in the landscape of cancer therapy.

Mol Cancer. 2023-6-21

[9]
Sotorasib in p.G12C-Mutated Advanced Pancreatic Cancer.

N Engl J Med. 2023-1-5

[10]
Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial.

Lancet Gastroenterol Hepatol. 2023-2

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索